Scientists / Publications

Publications

Genentech scientists are encouraged to be creative and active members of the scientific community. We are proud of our publication record in Science, Nature, Cell, and other prestigious peer-reviewed journals, where our annual output consistently rivals or surpasses that of the top academic institutions.

DISPLAYING 4801 - 4850 OF 15390 RESULTS

Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration
Retina, ISSN: 15392864 0275004X
Srinivas Sadda; Usha Chakravarthy; David G. Birch; Giovanni Staurenghi; Erin C. Henry; Christopher Brittain
View on Scopus
Regulation of interleukin-10 expression
Advances in Experimental Medicine and Biology, ISSN: 22148019 00652598
Sascha Rutz; Wenjun Ouyang
View on Scopus
Peripheral blood gene expression predicts clinical benefit from anti–IL-13 in asthma
Journal of Allergy and Clinical Immunology, ISSN: 10976825 00916749
David F. Choy; Guiquan Jia; Abbas Alexander; Katrina B. Morshead; Nicholas Lewin-Koh; Rajiv Dua; Pauline Rivera; Priscilla Moonsamy; Marcel Fontecha; Aarthi Balasubramanyam; Chris Santini; Ekaterina Bassett; Jill M. Ray; Christopher R. Cabanski; Mary S. Bradley; Romeo MacIuca; Mosesova; Heleen Scheerens; Joseph R. Arron
View on Scopus
Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Seminars in Arthritis and Rheumatism, ISSN: 1532866X 00490172
Michael S. Broder; Khaled Sarsour; Eunice Chang; Neil Collinson; Katie Tuckwell; Pavel Napalkov; Micki Klearman
View on Scopus
Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?
CPT: Pharmacometrics and Systems Pharmacology, ISSN: 21638306
Ian E. Templeton; Yuan Chen; Jialin Mao; Jian Lin; Hongbin Yu; Peters; Shebley; Varma
View on Scopus
Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN cancer research group (E1496)
Cancer, ISSN: 10970142 0008543X
Stefan K. Barta; Hailun Li; Hochster; Fangxin Hong; Edie Weller; Randy D. Gascoyne; Thomas M. Habermann; Leo I. Gordon; Natalia Colocci; Elizabeth M. Bengtson; Sandra J. Horning; Brad Kahl
View on Scopus
Using the HistoPress embedding tool to process murine colon samples for histopathology
Journal of Histotechnology, ISSN: 20460236 01478885
Susan Haller; Victor Nunez; Charles Havnar; Noa Safra; Oded Foreman
View on Scopus
Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
Journal of Gastroenterology and Hepatology (Australia), ISSN: 14401746 08159319
Jia-Horng Kao; Shui-Yi Tung; Younjae Lee; Satawat Thongsawat; Tanwandee; I.-Shyan Sheen; Jinzi J. Wu; Hui Li; Barbara J. Brennan; Julian Zhou; Sophie Le Pogam; Nájera; James A. Thommes; George Hill
View on Scopus
Considerations on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment of Medical Product
Statistics in Biopharmaceutical Research, ISSN: 19466315
Haijun Ma; Qi Jiang; Christy Chuang-Stein; Scott R. Evans; Weili He; George Quartey; John Scott; Shihua Wen; Ramin Arani
View on Scopus
Selecting and Integrating Data Sources in Benefit–Risk Assessment: Considerations and Future Directions
Statistics in Biopharmaceutical Research, ISSN: 19466315
Rachael L. DiSantostefano; Jesse A. Berlin; Christy Chuang-Stein; George Quartey; Gary Eichenbaum; Bennett Levitan
View on Scopus
Practical Analysis and Visualization Tools for Benefit-Risk Assessment in Drug Development: A Review of Recent FDA Advisory Committee Meeting Packages
Statistics in Biopharmaceutical Research, ISSN: 19466315
Shihua Wen; Weili He; Scott R. Evans; George Quartey; Jonathan D. Norton; Christy Chuang-Stein; Qi Jiang; Haijun Ma; Mondira Bhattacharya
View on Scopus
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases, ISSN: 14682060 00034967
Cem Gabay; McInnes; Arthur Kavanaugh; Katie Tuckwell; Micki Klearman; Jennifer Pulley; Naveed Sattar
View on Scopus
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
Annals of Oncology, ISSN: 15698041 09237534
Fumagalli; Wilson; Roberto Salgado; Xuyang Lu; Yu; Carol O'Brien; Kimberly Walter; Huw; Carmen Criscitiello; Laios; Jose; Brown; Rothé; Maetens; Zardavas; Peter Savas; Denis Larsimont; Martine Piccart; Stefan Michiels; Lackner; Christos Sotiriou; Sherene Loi
View on Scopus
Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN cancer research group (E1496)
Cancer, ISSN: 10970142 0008543X
Stefan K. Barta; Hailun Li; Hochster; Fangxin Hong; Edie Weller; Randy D. Gascoyne; Thomas M. Habermann; Leo I. Gordon; Natalia Colocci; Elizabeth M. Bengtson; Sandra J. Horning; Wojciech Jurczak
View on Scopus
Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study
Annals of Oncology, ISSN: 15698041 09237534
Yohann Loriot; Jonathan E. Rosenberg; Thomas Powles; Andrea Necchi; Syed Hussain; Morales; Margitta M. Retz; Günter Niegisch; Ignacio Durán; Christine Théodore; Jose Luis Perez-Gracia; Grande Pulido; AnnChristine Thåström; Bradford Danner; Sanjeev Mariathasan; Oyewale Abidoye; Michiel S Van Der Heijden
View on Scopus
Second-line metastatic urothelial carcinoma treatment and survival in real-world patients in the US
Annals of Oncology, ISSN: 15698041 09237534
Sumanta Kumar Pal; Matthew D. Galsky; Shih Wen Lin; Sarika Ogale; Marko Zivkovic; Simpson; Christina L. Derleth; Guru Sonpavde
View on Scopus
PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
Annals of Oncology, ISSN: 15698041 09237534
De Bono; De Giorgi; Christophe Massard; Sergio Bracarda; Nava Rodrigues; Ivo Kocak; Albert Font; J. Arranz Arija; Shih; George Daniel Radavoi; Yu; Wai Y. Chan; Steven Gendreau; Zhang; Ruth Riisnaes; Matthew Wongchenko; Daniel Maslyar; Viorel Jinga
View on Scopus
A real-world study of patterns of Bacillus Calmette-Guerin (BCG) use and associated adverse events (AEs) in non-muscle invasive bladder cancer (NMIBC) patients in the United States
Annals of Oncology, ISSN: 15698041 09237534
Kathleen Wilson; Elisabetta Malangone-Monaco; Sacha Satram-Hoang; Diakun; Lin; Darren Tayama; Sarika Ogale
View on Scopus
Safety, clinical activity and biomarkers of atezolizumab (atezo) in advanced ovarian cancer (OC)
Annals of Oncology, ISSN: 15698041 09237534
Jeffery R. Infante; Fadi S. Braiteh; Leisha A. Emens; Ani Balmanoukian; Ana Oaknin; Yan Wang; Liu; Luciana L. Molinero; Marcella Fassò; Carol E. O'Hear; Michael S. Gordon
View on Scopus
A retrospective, real-world study of treatment patterns and outcomes among metastatic urothelial cancer (mUC) patients in the United States
Annals of Oncology, ISSN: 15698041 09237534
Elisabetta Malangone-Monaco; Sacha Satram-Hoang; Kathleen Wilson; Helen Varker; Lin; Darren Tayama; Sarika Ogale
View on Scopus
Primary analysis from OAK, a randomized phase III study comparing atezolizumab with docetaxel in 2L/3L NSCLC
Annals of Oncology, ISSN: 15698041 09237534
Fabrice Barlesi; Park; Fortunato Ciardiello; Joachim Von Pawel; Shirish M. Gadgeel; Toyoaki Hida; Dariusz M Kowalski; Manuel Cobo Dols; Diego L Cortinovis; Joseph W. Leach; Jonathan Polikoff; David R. Gandara; Carlos H. Barrios; Daniel S. Chen; Pei He; Marcin Kowanetz; Ballinger; Waterkamp; Alan Sandler; Achim Rittmeyer
View on Scopus
A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (Pts) with solid tumors
Annals of Oncology, ISSN: 15698041 09237534
Shanu Modi; Joseph Paul Eder; Patricia M. LoRusso; Colin D. Weekes; Sarat Chandarlapaty; Tolaney; McLaughlin; D. Ross Camidge; Chang; Denise Nazzal; Chen; Schuth; Flavia Brunstein; Darbonne; W. Michael Flanagan; Alexander Ungewickell; Geoffrey I. Shapiro
View on Scopus
First-line cobimetinib (C) + paclitaxel (P) in patients (pts) with advanced triple-negative breast cancer (TNBC): Updated results and tumoral immune cell infiltration data from the phase 2 COLET study
Annals of Oncology, ISSN: 15698041 09237534
David W. Miles; Kim; Velu; Garcia-Saenz; Elizabeth Tan-Chiu; Sohn; Luc Dirix; Vanˇásek; Borms; J. Ilgado De Mingorance; Liu; Moezi; Kozloff; Joseph Sparano; Xu; Yan; Matthew Wongchenko; Brian Simmons; Virginia McNally; Adam Brufsky
View on Scopus
The SP142 PD-L1 IHC assay for atezolizumab (atezo) reflects pre-existing immune status in NSCLC and correlates with PD-L1 mRNA
Annals of Oncology, ISSN: 15698041 09237534
Williams; Marcin Kowanetz; Koeppen; Zachary Boyd; Edward E. Kadel III; Dustin Smith; Mark L. McCleland; Wei Zou; Priti Hegde
View on Scopus
SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with oestrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with PIK3CA-mutant tumours
Annals of Oncology, ISSN: 15698041 09237534
Baselga; Cortes Castan; De Laurentiis; Diéras; Nadia Harbeck; Hsu; Huan Jin; Frauke Schimmoller; Wilson; Im; William Jacot; Ian E. Krop; Sunil Verma
View on Scopus
Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors
Annals of Oncology, ISSN: 15698041 09237534
Phillip J. Stephens; Travis A. Clark; Mark Kennedy; He; Young; Mandy Zhao; Michael Coyne; Virginia Breese; Young; Shan Zhong; Mark Bailey; Bernard Fendler; Vincent A. Miller; Erica Schleifman; Peters; Geoff A. Otto; Doron Lipson; Jeffrey S. Ross
View on Scopus
Genomic features of complete responders (CR) versus fast progressors (PD) in patients with BRAFV600-mutated metastatic melanoma treated with cobimetinib + vemurafenib or vemurafenib alone
Annals of Oncology, ISSN: 15698041 09237534
Yan; Caroline Robert; James Larkin; Paolo A. Ascierto; Brigitte Dréno; Michele Maio; Claus Garbe; Paul B. Chapman; Jeffrey A. Sosman; Matthew Wongchenko; Jessie Hsu; Ilsung Chang; Ivor Caro; Isabelle Rooney; McArthur; Antoni Ribas
View on Scopus
Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
Annals of Oncology, ISSN: 15698041 09237534
Lecia V. Sequist; Chiang; Gilbert; Michael S. Gordon; Paul Conkling; Thompson; Marcoux; Scott J. Antonia; Liu; David S. Shames; Ariel Lopez-Chavez; Carol E. O'Hear; Marcella Fassò; Scott Gettinger
View on Scopus
Prognostic subgroups and impact of treatment for post-progression overall survival (ppOS) in patients (pts) with BRAFV600-mutated metastatic melanoma treated with dacarbazine (DTIC) or vemurafenib (VEM) ± cobimetinib (COBI): A pooled analysis
Annals of Oncology, ISSN: 15698041 09237534
Paolo A. Ascierto; Antoni Ribas; James Larkin; McArthur; Karl Lewis; Axel Hauschild; Keith Flaherty; Edward McKenna; Qian Zhu; Yong Mun; Brigitte Dréno
View on Scopus
Efficacy and safety of cobimetinib (cobi) and atezolizumab (atezo) in an expanded phase 1b study of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)
Annals of Oncology, ISSN: 15698041 09237534
Jayesh Desai; Hong; Kim; Kim; Han; Bang; Chee; Heong; McRee; Laura Q.M. Chow; Eunice Kwak; Jeffery R. Infante; Jeffery J. Wallin; M. Das Thakur; Mwawasi; Paul Foster; Edward Cha; Bendell
View on Scopus
Preliminary safety and clinical activity of atezolizumab combined with cobimetinib and vemurafenib in BRAF V600-mutant metastatic melanoma
Annals of Oncology, ISSN: 15698041 09237534
Patrick Hwu; Omid Hamid; Rene Gonzalez; Jeffery R. Infante; Manish R. Patel; F. Stephen Hodi; Karl Lewis; Jeffery J. Wallin; Mwawasi; Edward Cha; Nicole A. Richie; Ballinger; Richard Sullivan
View on Scopus
Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC
Annals of Oncology, ISSN: 15698041 09237534
Marcin Kowanetz; Wei Zou; David S. Shames; Cummings; Naiyer A. Rizvi; Alexander Spira; Garrett M Frampton; Vincent Leveque; Susan Flynn; Mocci; Geetha Shankar; Roel Funke; Ballinger; Waterkamp; Alan Sandler; Garret M. Hampton; Lukas Amler; Priti Hegde; Matthew D. Hellmann
View on Scopus
A real-world study of patterns of Bacillus Calmette-Guerin (BCG) use and associated adverse events (AEs) in non-muscle invasive bladder cancer (NMIBC) patients in the United States
Annals of Oncology, ISSN: 15698041 09237534
Kathleen Wilson; Elisabetta Malangone-Monaco; Sacha Satram-Hoang; Diakun; Shih-Wen Lin; Darren Tayama; Sarika Ogale
View on Scopus
Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC
Annals of Oncology, ISSN: 15698041 09237534
Marcin Kowanetz; Wei Zou; David S. Shames; Cummings; Naiyer A. Rizvi; Alexander Spira; Garrett M Frampton; Vincent Leveque; Susan Flynn; Mocci; Geetha Shankar; Roel Funke; Ballinger; Waterkamp; Alan Sandler; Garret M. Hampton; Lukas Amler; Priti Hegde; Matthew D. Hellmann
View on Scopus
A retrospective, real-world study of treatment patterns and outcomes among metastatic urothelial cancer (mUC) patients in the United States
Annals of Oncology, ISSN: 15698041 09237534
Elisabetta Malangone-Monaco; Sacha Satram-Hoang; Kathleen Wilson; Helen Varker; Shih-Wen Lin; Darren Tayama; Sarika Ogale
View on Scopus
Safety, clinical activity and biomarkers of atezolizumab (atezo) in advanced ovarian cancer (OC)
Annals of Oncology, ISSN: 15698041 09237534
Jeffery R. Infante; Fadi S. Braiteh; Leisha A. Emens; Ani Balmanoukian; Ana Oaknin; Yan Wang; Bo Liu; Luciana L. Molinero; Marcella Fassò; Carol E. O'Hear; Michael S. Gordon
View on Scopus
Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors
Annals of Oncology, ISSN: 15698041 09237534
Phillip J. Stephens; Travis A. Clark; Mark Kennedy; He; Young; Mandy Zhao; Michael Coyne; Virginia Breese; Young; Shan Zhong; Mark Bailey; Bernard Fendler; Vincent A. Miller; Erica Schleifman; Peters; Geoff A. Otto; Doron Lipson; Jeffrey S. Ross
View on Scopus
A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (Pts) with solid tumors
Annals of Oncology, ISSN: 15698041 09237534
Modi; Joseph Paul Eder; Patricia M. LoRusso; Colin D. Weekes; Sarat Chandarlapaty; Tolaney; McLaughlin; D. Ross Camidge; Chang; Denise Nazzal; Chen; Schuth; Flavia Brunstein; Darbonne; W. Michael Flanagan; Alexander Ungewickell; Geoffrey I. Shapiro
View on Scopus
PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
Annals of Oncology, ISSN: 15698041 09237534
De Bono; Ugo De Giorgi; Christophe Massard; Sergio Bracarda; Nava Rodrigues; Ivo Kocak; Albert Font; Jose Angel Arranz Arija; Shih; George Daniel Radavoi; Wei Yu; Wai Y. Chan; Steven Gendreau; Liangxuan Zhang; Ruth Riisnaes; Matthew Wongchenko; Daniel Maslyar; Viorel Jinga
View on Scopus
Primary analysis from OAK, a randomized phase III study comparing atezolizumab with docetaxel in 2L/3L NSCLC
Annals of Oncology, ISSN: 15698041 09237534
Fabrice Barlesi; Park; Fortunato Ciardiello; Joachim Von Pawel; Shirish M. Gadgeel; Hida; Dariusz M Kowalski; Manuel Cobo Dols; Diego L Cortinovis; Joseph W. Leach; Jonathan Polikoff; David R. Gandara; Carlos H. Barrios; Chen; Pei He; Marcin Kowanetz; Ballinger; Waterkamp; Alan Sandler; Achim Rittmeyer
View on Scopus
First-line cobimetinib (C) + paclitaxel (P) in patients (pts) with advanced triple-negative breast cancer (TNBC): Updated results and tumoral immune cell infiltration data from the phase 2 COLET study
Annals of Oncology, ISSN: 15698041 09237534
David W. Miles; Sung-Bae Kim; Velu; Garcia-Saenz; Elizabeth Tan-Chiu; Sohn; Luc Dirix; Vanˇásek; Borms; J. Ilgado De Mingorance; Liu; Moezi; Kozloff; Joseph Sparano; Xu; Yibing Yan; Matthew Wongchenko; Brian Simmons; Virginia McNally; Adam Brufsky
View on Scopus
Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study
Annals of Oncology, ISSN: 15698041 09237534
Yohann Loriot; Jonathan E. Rosenberg; Thomas Powles; Andrea Necchi; Syed Hussain; Morales; Margitta M. Retz; Günter Niegisch; Ignacio Durán; Christine Théodore; Jose Luis Perez-Gracia; Grande Pulido; AnnChristine Thåström; Bradford Danner; Sanjeev Mariathasan; Oyewale Abidoye; Michiel S Van Der Heijden
View on Scopus
Genomic features of complete responders (CR) versus fast progressors (PD) in patients with BRAFV600-mutated metastatic melanoma treated with cobimetinib + vemurafenib or vemurafenib alone
Annals of Oncology, ISSN: 15698041 09237534
Yibing Yan; Caroline Robert; James Larkin; Paolo A. Ascierto; Brigitte Dréno; Michele Maio; Claus Garbe; Paul B. Chapman; Jeffrey A. Sosman; Matthew Wongchenko; Hsu; Chang; Ivor Caro; Isabelle Rooney; McArthur; Antoni Ribas
View on Scopus
SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with oestrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with PIK3CA-mutant tumours
Annals of Oncology, ISSN: 15698041 09237534
Baselga; Cortes Castan; De Laurentiis; Diéras; Nadia Harbeck; Jerry Y. Hsu; Jin; Frauke Schimmoller; Wilson; Im; William Jacot; Ian E. Krop; Sunil Verma
View on Scopus
Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
Annals of Oncology, ISSN: 15698041 09237534
Lecia V. Sequist; Chiang; Gilbert; Michael S. Gordon; Paul Conkling; Thompson; Marcoux; Scott J. Antonia; Bo Liu; David S. Shames; Ariel Lopez-Chavez; Carol E. O'Hear; Marcella Fassò; Scott Gettinger
View on Scopus
The SP142 PD-L1 IHC assay for atezolizumab (atezo) reflects pre-existing immune status in NSCLC and correlates with PD-L1 mRNA
Annals of Oncology, ISSN: 15698041 09237534
Williams; Marcin Kowanetz; Koeppen; Zachary Boyd; Edward E. Kadel III; Dustin Smith; Mark L. McCleland; Wei Zou; Priti Hegde
View on Scopus
Preliminary safety and clinical activity of atezolizumab combined with cobimetinib and vemurafenib in BRAF V600-mutant metastatic melanoma
Annals of Oncology, ISSN: 15698041 09237534
Patrick Hwu; Omid Hamid; Rene Gonzalez; Jeffery R. Infante; Manish R. Patel; F. Stephen Hodi; Karl Lewis; Jeffery J. Wallin; Mwawasi; Edward Cha; Nicole A. Richie; Ballinger; Ryan J. Sullivan
View on Scopus
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors
Journal of Medicinal Chemistry, ISSN: 15204804 00222623
Mark Zak; Po-Wai Yuen; Xiongcai Liu; Snahel Patel; Deepak Sampath; Jason Oeh; Bianca M. Liederer; Weiru Wang; Thomas O'Brien; Yang Xiao; Nicholas J. Skelton; Rongbao Hua; Jasleen K. Sodhi; Yunli Wang; Lei Zhang; Guiling Zhao; Xiaozhang Zheng; Yen-Ching Ho; Kenneth W. Bair; Peter Dragovich
View on Scopus
Developing HSCs become Notch independent by the end of maturation in the AGM region
Blood, ISSN: 15280020 00064971
Céline Souilhol; Javier G. Lendinez; Stanislav Rybtsov; Fiona Murphy; Heather Wilson; David Hills; Antoniana Batsivari; Anahí Binagui-Casas; Alison C. McGarvey; H. Robson MacDonald; Kageyama; Christian W. Siebel; Suling Zhao; Alexander Medvinsky
View on Scopus
Structural Characterization of Cross-Linked Species in Trastuzumab Emtansine (Kadcyla)
Bioconjugate Chemistry, ISSN: 15204812 10431802
Yan Chen; Michael Kim; Laura Zheng; Galahad Deperalta; Fred Jacobson
View on Scopus
© 2024 Genentech, Inc. All rights reserved. This site is intended for US residents only.